✦ LIBER ✦

Are All Interferons the Same for Therapy in Polycythemia Vera?

✍ Scribed by Silver, Richard T.

Book ID: 122295318
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 79 KB
Volume: 13
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2013.05.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon γ Assays in the Diagnosis of

Interferon γ Assays in the Diagnosis of Tuberculosis Infection in Psoriasis Patients Who Are Candidates for Biologic Therapies

✍ J. Domínguez; M. Vilavella; I. Latorre 📂 Article 📅 2012 🏛 Elsevier Science 🌐 Spanish ⚖ 375 KB

Single-nucleotide polymorphisms in GALNT

Single-nucleotide polymorphisms in GALNT8 are associated with the response to interferon therapy for chronic hepatitis C

✍ Nakano, R.; Maekawa, T.; Abe, H.; Hayashida, Y.; Ochi, H.; Tsunoda, T.; Kumada, 📂 Article 📅 2013 🏛 Society for General Microbiology 🌐 English ⚖ 684 KB

Amantidine is not effective in clearing

Amantidine is not effective in clearing HCV from the serum in patients who are not candidates for interferon therapy

✍ Wiley, T.E.; Mihalov, M.; O'Riordan, K.; Layden, T.J.; Lam, N.P. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Switch to Everolimus for Sirolimus-Induc

Switch to Everolimus for Sirolimus-Induced Pneumonitis in a Liver Transplant Recipient—Not All Proliferation Signal Inhibitors Are the Same: A Case Report

✍ P. De Simone; S. Petruccelli; A. Precisi; P. Carrai; R. Doria; F. Menichetti; F. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Invertebrate Seed Predators are not all

Invertebrate Seed Predators are not all the Same: Seed Predation by Bruchine and Scolytine Beetles Affects Palm Recruitment in Different Ways

✍ Caroline M. Dracxler; Alexandra S. Pires; Fernando A. S. Fernandez 📂 Article 📅 2010 🏛 Association for Tropical Biology and Conservation 🌐 English ⚖ 154 KB

Mutations in the X region and core promo

Mutations in the X region and core promoter are rare and have little impact on response to interferon therapy for chronic hepatitis B

✍ Charles Hannoun; Peter Horal; Kim Krogsgaard; Magnus Lindh 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

## Abstract Therapy for chronic hepatitis B with interferon‐α (IFN) may result in viral clearance and hepatitis B e seroconversion in 30–40% of patients. It is still unclear whether viral genetic variability influences response rates. However, certain core promoter mutations were recently associate